DuPont falls on earnings, but investors might want to buy on weakness

The market didn't like DuPont's (DD) third-quarter earnings report, sending shares of the chemical giant down as much as three percent during Tuesday's session. This component of the Dow Jones Industrial Average ($INDU) easily beat Wall Street's profit estimate, but sales across all DuPont's businesses were down.

DuPont's stock has been a market beater so far this year, rising 37 percent to outpace the S&P 500 ($INX) by 15 percentage points. Perhaps today's stumble offers investors a chance to buy the blue chip on weakness. Shares go for just 16 times forward earnings, offering a discount of about 20 percent to the broader market. That's an intriguing relative valuation. Perhaps most attractive is DuPont's dividend. The share-price slide has boosted the yield to 4.8 percent.
Read Full Story

Markets

DJIA 25,659.25 100.52 0.39%
NASDAQ 7,800.40 -6.12 -0.08%
NIKKEI 225 22,270.38 78.34 0.35%
HANG SENG 27,213.41 113.35 0.42%
DAX 12,210.55 -26.62 -0.22%
USD (per EUR) 1.14 0.00 0.37%
USD (per CHF) 0.99 0.00 -0.29%
JPY (per USD) 110.43 -0.56 -0.51%
GBP (per USD) 1.27 0.00 0.21%